ScoreWhy is Biogened SA ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 8.84% signifying low profitability per unit of shareholders funds
2
Negative results in Mar 25
- INTEREST(Q) Highest at PLN 1.03 MM
3
With ROE of 10.45%, it has a fair valuation with a 1.33 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -30.00%, its profits have risen by 2.5% ; the PEG ratio of the company is 5.2
4
Below par performance in long term as well as near term
- Along with generating -30.00% returns in the last 1 year, the stock has also underperformed Poland WIG in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Biogened SA should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biogened SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Biogened SA
-22.22%
0.10
61.42%
Poland WIG
34.87%
1.84
20.56%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.77%
EBIT Growth (5y)
17.39%
EBIT to Interest (avg)
4.85
Debt to EBITDA (avg)
1.29
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
1.72
Tax Ratio
33.00%
Dividend Payout Ratio
42.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.92%
ROE (avg)
8.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.33
EV to EBIT
9.58
EV to EBITDA
6.30
EV to Capital Employed
1.23
EV to Sales
0.69
PEG Ratio
5.19
Dividend Yield
105.04%
ROCE (Latest)
12.85%
ROE (Latest)
10.45%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -2.99% (YoY
CASH AND EQV(HY)
Highest at PLN 10.92 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 37.29 %
NET SALES(Q)
Highest at PLN 32.85 MM
PRE-TAX PROFIT(Q)
Highest at PLN 3.45 MM
NET PROFIT(Q)
Highest at PLN 2.31 MM
EPS(Q)
Highest at PLN 0.94
-3What is not working for the Company
INTEREST(Q)
Highest at PLN 1.03 MM
Here's what is working for Biogened SA
Net Sales
Highest at PLN 32.85 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (PLN MM)
Pre-Tax Profit
Highest at PLN 3.45 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (PLN MM)
Net Profit
Highest at PLN 2.31 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (PLN MM)
EPS
Highest at PLN 0.94
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (PLN)
Cash and Eqv
Highest at PLN 10.92 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 37.29 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -2.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at PLN 1.08 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (PLN MM)
Here's what is not working for Biogened SA
Interest
At PLN 1.03 MM has Grown at 553.11%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (PLN MM)
Interest
Highest at PLN 1.03 MM
in the last five periods and Increased by 553.11% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (PLN MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
